Edition:
United States

Loxo Oncology Inc (LOXO.OQ)

LOXO.OQ on NASDAQ Stock Exchange Global Market

135.00USD
7 Dec 2018
Change (% chg)

$-0.17 (-0.13%)
Prev Close
$135.17
Open
$134.25
Day's High
$137.38
Day's Low
$132.26
Volume
144,270
Avg. Vol
110,778
52-wk High
$208.78
52-wk Low
$75.87

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 42.47 -0.887
Jun '18 42.60 -0.389
Mar '18 38.43 -0.119
FY 2017 Dec '17 21.30 -0.688
Sep '17 0.00 -2.454
Jun '17 0.00 -1.143
Mar '17 0.00 -0.956
FY 2016 Dec '16 0.00 -1.260
Sep '16 0.00 -0.819
Jun '16 0.00 -0.773
Mar '16 0.00 -0.593
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 10 58.58 99.25 45.40 23.59
Quarter Ending Mar-19 5 50.48 75.40 30.70 13.62
Year Ending Dec-18 11 178.32 224.00 139.37 31.34
Year Ending Dec-19 9 174.39 396.90 15.60 97.47
Earnings (per share)
Quarter Ending Dec-18 11 -0.81 -0.04 -1.23 -0.84
Quarter Ending Mar-19 6 -0.70 -0.06 -1.71 -0.83
Year Ending Dec-18 10 -2.16 -1.43 -2.60 -5.04
Year Ending Dec-19 10 -3.26 3.20 -9.08 -4.42
LT Growth Rate (%) 1 37.00 37.00 37.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 5.67 15.60 5.12
Price to Tangible Book (MRQ) 5.67 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions -- 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -47.91 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -60.01 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 42.15 5.42 3.11
LT Debt to Equity (MRQ) 0.00 33.58 11.47
Total Debt to Equity (MRQ) 0.00 35.41 15.63
Interest Coverage (TTM) -- -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -- -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -- -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,363 898,926,015
Net Income/Employee (TTM) -3,441,862 2,194,067 106,550,787
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.82 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -31.65 0.28 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -31.65 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -63.08 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Loxo Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.65 10.70 76 57
13 Week 14.21 8.65 69 62
26 Week 83.39 69.45 90 81
52 Week 280.96 222.90 97 47
YTD 172.96 139.71 93 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.42%
# of Holders: 326
Total Shares Held: 30,437,830
3 Mo. Net Change: -298,413
# New Positions: 42
# Closed Positions: 27
# Increased Positions: 167
# Reduced Positions: 118
# Net Buyers: 49
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.